News

Bioprojet and Endo Jointly Announce Agreement for Paladin Labs Inc. to Commercialize Pitolisant in Canada

Know more

Bioprojet will be taking part in the ESRS Congress in Basel, from the 25th to the 29th September.

Know more

Bioprojet at the 47th Annual meeting Histamine Research Society

Know more

Bioprojet: Pitolisant Progresses Towards the U.S. Market

Know more

AOP Orphan will distribute Wakix® (pitolisant) from Bioprojet Pharma in Austria, Nordic countries and Central Eastern Europe

Know more

Harmony biosciences acquires us rights to pitolisant from bioprojet; raises $270 million in equity financing

Know more